Edwards Lifesciences Corp
Here’s whether Edwards Lifesciences Corp (EW) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.12% over 10 days); strong 1-year return of +17.2%; 3-month momentum positive (+12.6%). Concerns: RSI 77 — overbought, elevated pullback risk; declining volume on rally — weak conviction (0.71x 30d avg). Currently 4.9% off its 52-week high. Score: +4/7.
EW is in a confirmed uptrend, trading above both its 50-day ($88.57) and 200-day ($84.45) moving averages. With an RSI of 77.4, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +17.2% compares to +20.4% for SPY (trailed the market by 3.2%).